skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 4,108  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Database: BMJ Open Access Journals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
9 MOG associated encephalitis presenting as idiopathic intracranial hypertension
9 MOG associated encephalitis presenting as idiopathic intracranial hypertension
Material Type:
Article 		Add to My Research

9 MOG associated encephalitis presenting as idiopathic intracranial hypertension

BMJ open ophthalmology, 2023-10, Vol.8 (Suppl 3), p.A3-A3 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2397-3269 ;EISSN: 2397-3269 ;DOI: 10.1136/bmjophth-2023-BIPOSA.9

Full text available

Citations Cited by
2
039 Prevalence of MRI signs of intracranial hypertension and their association with papilledema: a prospective study using ocular fundus photography
039 Prevalence of MRI signs of intracranial hypertension and their association with papilledema: a prospective study using ocular fundus photography
Material Type:
Article 		Add to My Research

039 Prevalence of MRI signs of intracranial hypertension and their association with papilledema: a prospective study using ocular fundus photography

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A15-A15 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2632-6140 ;DOI: 10.1136/bmjno-2021-ANZAN.39

Full text available

Citations Cited by
3
Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension
Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension
Material Type:
Article 		Add to My Research

Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension

Heart (British Cardiac Society), 2022-03, Vol.108 (5), p.382-387 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2021-319096 ;PMID: 34415851

Full text available

Citations Cited by
4
Restoration of right ventricular function in the treatment of pulmonary arterial hypertension
Restoration of right ventricular function in the treatment of pulmonary arterial hypertension
Material Type:
Article 		Add to My Research

Restoration of right ventricular function in the treatment of pulmonary arterial hypertension

Heart (British Cardiac Society), 2023-12, Vol.109 (24), p.1844-1850 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-322742 ;PMID: 37527919

Full text available

Citations Cited by
5
Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort
Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort
Material Type:
Article 		Add to My Research

Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort

Heart (British Cardiac Society), 2012-12, Vol.98 (24), p.1805-1811 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2014 INIST-CNRS ;Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2012 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2012-301992 ;PMID: 22760869

Full text available

Citations Cited by
6
Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study
Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study
Material Type:
Article 		Add to My Research

Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study

BMJ (Online), 2017-07, Vol.358, p.j3078-j3078 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2017 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.j3078 ;PMID: 28701333

Full text available

Citations Cited by
7
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
Material Type:
Article 		Add to My Research

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

Annals of the rheumatic diseases, 2017-07, Vol.76 (7), p.1219-1227 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-210236 ;PMID: 28039187

Full text available

Citations Cited by
8
Pre-eclampsia and risk of later kidney disease: nationwide cohort study
Pre-eclampsia and risk of later kidney disease: nationwide cohort study
Material Type:
Article 		Add to My Research

Pre-eclampsia and risk of later kidney disease: nationwide cohort study

BMJ (Online), 2019-04, Vol.365, p.l1516-l1516 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2019 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2019 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l1516 ;PMID: 31036557

Full text available

Citations Cited by
9
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response
Material Type:
Article 		Add to My Research

Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response

Heart (British Cardiac Society), 2022-09, Vol.108 (17), p.1392-1400 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 2022 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2021-320733 ;PMID: 35512982

Full text available

Citations Cited by
10
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era
Material Type:
Article 		Add to My Research

Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era

Annals of the rheumatic diseases, 2013-12, Vol.72 (12), p.1940-1946 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2013 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2012-202489 ;PMID: 23178295 ;CODEN: ARDIAO

Full text available

Citations Cited by
11
Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis
Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis
Material Type:
Article 		Add to My Research

Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis

Annals of the rheumatic diseases, 2020-05, Vol.79 (5), p.626-634 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-216274 ;PMID: 32161055

Full text available

Citations Cited by
12
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
Material Type:
Article 		Add to My Research

Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension

Thorax, 2019-04, Vol.74 (4), p.380-389 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. 2019 ;ISSN: 0040-6376 ;EISSN: 1468-3296 ;DOI: 10.1136/thoraxjnl-2018-212144 ;PMID: 30478197

Full text available

Citations Cited by
13
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
Material Type:
Article 		Add to My Research

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension

Gut, 2020-07, Vol.69 (7), p.1173-1192 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2019-320221 ;PMID: 32114503

Full text available

Citations Cited by
14
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
Material Type:
Article 		Add to My Research

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

Annals of the rheumatic diseases, 2014-07, Vol.73 (7), p.1340-1349 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2014 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2013-203301 ;PMID: 23687283 ;CODEN: ARDIAO

Full text available

Citations Cited by
15
TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension
TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension
Material Type:
Article 		Add to My Research

TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension

Journal of medical genetics, 2013-08, Vol.50 (8), p.500-506 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2013 ;ISSN: 0022-2593 ;ISSN: 1468-6244 ;EISSN: 1468-6244 ;DOI: 10.1136/jmedgenet-2012-101152 ;PMID: 23592887 ;CODEN: JMDGAE

Full text available

Citations Cited by
16
Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey
Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey
Material Type:
Article 		Add to My Research

Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey

BMJ (Online), 2023-01, Vol.380, p.e071952-e071952 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2023 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2022-071952 ;PMID: 36631148

Full text available

Citations Cited by
17
Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials
Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials
Material Type:
Article 		Add to My Research

Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials

BMJ (Online), 2013-04, Vol.346 (7903), p.12-12 [Peer Reviewed Journal]

He et al 2013 ;BMJ Publishing Group Ltd 2013 ;Copyright: 2013 © He et al 2013 ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;ISSN: 0959-8146 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.f1325 ;PMID: 23558162 ;CODEN: BMJOAE

Full text available

Citations Cited by
18
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)
Material Type:
Article 		Add to My Research

Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)

BMJ open respiratory research, 2023-12, Vol.10 (1), p.e001917 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 2052-4439 ;EISSN: 2052-4439 ;DOI: 10.1136/bmjresp-2023-001917 ;PMID: 38061804

Full text available

Citations Cited by
19
The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study
The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study
Material Type:
Article 		Add to My Research

The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study

BMJ (Online), 2017-05, Vol.357, p.j1794-j1794 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2017 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.j1794 ;PMID: 28487277

Full text available

Citations Cited by
20
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
Material Type:
Article 		Add to My Research

High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis

Heart (British Cardiac Society), 2014-06, Vol.100 (11), p.855-861 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2014 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2013-305063 ;PMID: 24694797

Full text available

Citations Cited by

Results 1 - 20 of 4,108  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2002  (4)
  2. 2002 To 2009  (46)
  3. 2010 To 2013  (287)
  4. 2014 To 2018  (1,004)
  5. After 2018  (2,768)
  6. More options open sub menu

Resource Type 

  1. Articles  (4,105)
  2. Conference Proceedings  (3)
  3. More options open sub menu

Subject 

  1. Life Sciences & Biomedicine  (3,813)
  2. Science & Technology  (3,813)
  3. Hypertension  (3,754)
  4. Humans  (2,611)
  5. General & Internal Medicine  (2,455)
  6. Medicine, General & Internal  (2,414)
  7. Diabetes  (2,183)
  8. Female  (1,536)
  9. Cardiovascular Disease  (1,519)
  10. Patients  (1,463)
  11. Blood Pressure  (1,437)
  12. Male  (1,342)
  13. Risk Factors  (1,288)
  14. Mortality  (1,222)
  15. Middle Aged  (1,083)
  16. Adult  (988)
  17. Population  (976)
  18. Aged  (970)
  19. Epidemiology  (967)
  20. Body Mass Index  (926)
  21. More options open sub menu

Language 

  1. Japanese  (311)
  2. Norwegian  (18)
  3. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait